Govt mulls launching PLI scheme for chemical sector to boost manufacturing

The government is considering launching a production linked incentive (PLI) scheme in the chemical sector to boost domestic manufacturing and exports.

pharma, chemicals
Press Trust of India New Delhi
2 min read Last Updated : Mar 05 2021 | 11:50 PM IST

The government is considering launching a production linked incentive (PLI) scheme in the chemical sector to boost domestic manufacturing and exports.

Addressing a webinar on 'Implementation Strategy of Budget Announcement 2021-22', Chemicals and Fertilisers Minister D V Sadananda Gowda on Friday said the government is working on a consultative approach in forming the policies for India's chemicals and petrochemicals sector.

The webinar was organised by the Department of Chemicals & Petrochemicals and FICCI.

"Implementations of the Budget announcements cannot be done only by the government.

"We should take our industry in confidence so that implementations can start from first week of April. The challenge for the government is to now match the suggestions of the industry with the implementation part, he was quoted as saying in a FICCI statement.

Gowda said the Budget has provided a boost to the Indian pharmaceutical sector.

The big push for the pharma sector is being seen as an attempt to discourage the imports of raw materials that are widely used in local manufacturing, he said.

Mansukh Mandaviya, Minister of State for Chemicals & Fertilizers, said that the government is working to introduce PLI scheme for the chemicals sector to increase domestic production, according to FICCI statement.

There are immense opportunities for the industry and the government is working to ensure to provide all necessary support, he added.

The government decides on policies after a thorough research on ground and wants to make the industry competitive. We have to encash the opportunity, he added.

Mandaviya further said that India has both the potential and the manpower to deal with the pandemic.

The result of medicine diplomacy has been such that the entire world now wants to procure vaccines from India, he said.

After supplying medicines to 120 countries, no country has complained of inferior quality medicine.

The Indian industry, its entrepreneurs and the Made in India stamp have set a benchmark globally, he noted.

(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

Topics :PLI schememanufacturing

First Published: Mar 05 2021 | 11:48 PM IST

Next Story